Healthcare stakeholders hold different perceptions of value-based care, with some stakeholders associating “value” with sub-optimal care. A recent ISPOR article, published in Value & Outcomes Spotlight, discusses how to successfully navigate conversations regarding value. Related topics, such as determining the net cost of a treatment, using quality-adjusted life years (QALYs) to assess the value of a treatment, and incorporating real world evidence (RWE) pose additional challenges.
“The concept of value is complex, multidimensional, and varies according to the perspectives of the various stakeholders in our healthcare system. Subsequent articles in this series will include interviews with various stakeholders to explore their understanding of value. As we emerge from the COVID-19 pandemic, we have a unique opportunity to pause, reflect, and create a vision for the future that improves the value delivered and meets the future needs of an expanding society.” Read more here.
(Source: John Watkins, Value & Outcomes Spotlight, ISPOR, 5/2021)